Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 19.91
(-0.75%)
CNY 19.91
(-0.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 344.97 Million CNY | -12.93% |
| 2022 | 396.2 Million CNY | 0.84% |
| 2021 | 392.9 Million CNY | 22.2% |
| 2020 | 321.51 Million CNY | -6.37% |
| 2019 | 343.37 Million CNY | 26.54% |
| 2018 | 271.35 Million CNY | 25.5% |
| 2017 | 216.22 Million CNY | 38.63% |
| 2016 | 155.96 Million CNY | 16.29% |
| 2015 | 134.12 Million CNY | 19.32% |
| 2014 | 112.41 Million CNY | 37.6% |
| 2013 | 81.69 Million CNY | 35.34% |
| 2012 | 60.35 Million CNY | 46.59% |
| 2011 | 41.17 Million CNY | 120.94% |
| 2010 | 18.63 Million CNY | 90.58% |
| 2009 | 9.77 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 70.58 Million CNY | -5.48% |
| 2024 Q3 | 143.74 Million CNY | 103.66% |
| 2024 Q1 | 74.67 Million CNY | 68.24% |
| 2023 Q4 | 44.38 Million CNY | -68.49% |
| 2023 FY | 344.97 Million CNY | -12.93% |
| 2023 Q1 | 74.54 Million CNY | 275.86% |
| 2023 Q2 | 85.16 Million CNY | 14.25% |
| 2023 Q3 | 140.87 Million CNY | 65.41% |
| 2022 FY | 396.2 Million CNY | 0.84% |
| 2022 Q4 | 19.83 Million CNY | -88.29% |
| 2022 Q1 | 104.95 Million CNY | 41.94% |
| 2022 Q2 | 102.07 Million CNY | -2.74% |
| 2022 Q3 | 169.34 Million CNY | 65.89% |
| 2021 Q3 | 151.29 Million CNY | 74.5% |
| 2021 FY | 392.9 Million CNY | 22.2% |
| 2021 Q1 | 80.96 Million CNY | 22.96% |
| 2021 Q2 | 86.7 Million CNY | 7.09% |
| 2021 Q4 | 73.94 Million CNY | -51.13% |
| 2020 Q1 | 46.74 Million CNY | -22.41% |
| 2020 FY | 321.51 Million CNY | -6.37% |
| 2020 Q4 | 65.84 Million CNY | -50.88% |
| 2020 Q3 | 134.03 Million CNY | 78.97% |
| 2020 Q2 | 74.89 Million CNY | 60.2% |
| 2019 FY | 343.37 Million CNY | 26.54% |
| 2019 Q4 | 60.25 Million CNY | -54.86% |
| 2019 Q3 | 133.46 Million CNY | 83.79% |
| 2019 Q2 | 72.62 Million CNY | -5.73% |
| 2019 Q1 | 77.03 Million CNY | 52.39% |
| 2018 Q1 | 60.69 Million CNY | 40.14% |
| 2018 Q4 | 50.55 Million CNY | -49.04% |
| 2018 FY | 271.35 Million CNY | 25.5% |
| 2018 Q3 | 99.19 Million CNY | 62.81% |
| 2018 Q2 | 60.92 Million CNY | 0.38% |
| 2017 Q1 | 44.88 Million CNY | 48.05% |
| 2017 Q2 | 46.03 Million CNY | 2.55% |
| 2017 Q3 | 81.99 Million CNY | 78.12% |
| 2017 Q4 | 43.3 Million CNY | -47.18% |
| 2017 FY | 216.22 Million CNY | 38.63% |
| 2016 FY | 155.96 Million CNY | 16.29% |
| 2016 Q1 | 33.32 Million CNY | 11.27% |
| 2016 Q2 | 30.36 Million CNY | -8.89% |
| 2016 Q3 | 61.96 Million CNY | 104.09% |
| 2016 Q4 | 30.32 Million CNY | -51.07% |
| 2015 FY | 134.12 Million CNY | 19.32% |
| 2015 Q4 | 29.94 Million CNY | -35.26% |
| 2015 Q3 | 46.25 Million CNY | 58.73% |
| 2015 Q2 | 29.14 Million CNY | 1.29% |
| 2015 Q1 | 28.77 Million CNY | -3.55% |
| 2014 Q1 | 14.94 Million CNY | -12.46% |
| 2014 Q4 | 29.83 Million CNY | -27.97% |
| 2014 Q3 | 41.41 Million CNY | 58.01% |
| 2014 Q2 | 26.21 Million CNY | 75.37% |
| 2014 FY | 112.41 Million CNY | 37.6% |
| 2013 Q1 | 18.29 Million CNY | 33.52% |
| 2013 FY | 81.69 Million CNY | 35.34% |
| 2013 Q4 | 17.07 Million CNY | -40.95% |
| 2013 Q3 | 28.91 Million CNY | 66.18% |
| 2013 Q2 | 17.4 Million CNY | -4.9% |
| 2012 FY | 60.35 Million CNY | 46.59% |
| 2012 Q4 | 13.7 Million CNY | -42.76% |
| 2012 Q3 | 23.94 Million CNY | 0.0% |
| 2011 FY | 41.17 Million CNY | 120.94% |
| 2010 FY | 18.63 Million CNY | 90.58% |
| 2009 FY | 9.77 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 825.98 Million CNY | 58.235% |
| Zhejiang Zhenyuan Share Co., Ltd. | 113.04 Million CNY | -205.175% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -104.37 Million CNY | 430.499% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -141.05 Million CNY | 344.57% |
| Yifan Pharmaceutical Co., Ltd. | -882.71 Million CNY | 139.081% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 40.51 Million CNY | -751.46% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.65 Billion CNY | 90.559% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -56.7 Million CNY | 708.348% |
| Boai NKY Medical Holdings Ltd. | 585.23 Million CNY | 41.054% |